Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance
Authors:
- Alessandro MustazzoluAMAlessandro Mustazzolu
- Angelo IacobinoAngelo Iacobino
- Federico GiannoniFederico Giannoni
- the Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) GroupTGthe Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) Group
- Lanfranco FattoriniLanfranco Fattorini
Open Access
- 1 December 2017
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 55 (12) , 3552-3553
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute (CCM)
This publication has 14 references indexed in Scilit:
- Tuberculosis in migrants from 106 countries to Italy, 2008–2014European Respiratory Journal, 2016
- Systematic Review of Mutations in Pyrazinamidase Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2015
- Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter StudymBio, 2014
- Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experienceThe International Journal of Tuberculosis and Lung Disease, 2013
- Prevention of False Resistance Results Obtained in Testing the Susceptibility of Mycobacterium tuberculosis to Pyrazinamide with the Bactec MGIT 960 System Using a Reduced InoculumJournal of Clinical Microbiology, 2013
- Proficiency testing of first- and second-line anti-tuberculosis drugs in ItalyEuropean Respiratory Journal, 2012
- Validation of pncA Gene Sequencing in Combination with the Mycobacterial Growth Indicator Tube Method To Test Susceptibility of Mycobacterium tuberculosis to PyrazinamideJournal of Clinical Microbiology, 2012
- Potential for Erroneous Results Indicating Resistance When Using the Bactec MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to PyrazinamideJournal of Clinical Microbiology, 2010
- Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New ZealandPathology, 2009
- Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamideJournal of Medical Microbiology, 2002